Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
ItalyN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
ItalyPhase 1b-2 Study of Elacestrant and Abemaciclib in Patients with Brain Metastases from ER-Positive, HER2-Negative Breast Cancer
ItalyPhase 1/2 Evaluation of Zilovertamab Vedotin in PD-1/L1 Refractory Locally Advanced or Metastatic Urothelial Carcinoma
ItalyEfficacy and Safety of Subcutaneous Belimumab in Adults with Connective Tissue Disease-Associated Interstitial Lung Disease
ItalyEvaluation of mRNA-4359 Monotherapy and Combined Pembrolizumab Therapy in Advanced Solid Tumors: A Phase 1/2 Clinical Trial
ItalyItalyA study testing the safety and effectiveness of AZD0516 alone and with other cancer drugs in adults with metastatic prostate cancer
ItalyA study of finerenone with standard treatment for children and young adults from birth to 18 years with heart failure and left ventricular systolic dysfunction
ItalyA study of finerenone added to standard treatment in children aged 6 months to under 18 years with heart failure and reduced left heart pumping function
ItalyA Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones
ItalyA Study of Atumelnant for Children with Congenital Adrenal Hyperplasia
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
